Short Interest in Bavarian Nordic A/S (OTCMKTS:BVNRY) Declines By 33.9%

Bavarian Nordic A/S (OTCMKTS:BVNRY) was the recipient of a significant decrease in short interest during the month of December. As of December 15th, there was short interest totalling 4,100 shares, a decrease of 33.9% from the November 30th total of 6,200 shares. Based on an average daily volume of 34,900 shares, the days-to-cover ratio is presently 0.1 days.

Bavarian Nordic A/S Trading Up 0.8 %

OTCMKTS BVNRY opened at $8.98 on Monday. The business’s 50-day moving average price is $9.43 and its 200 day moving average price is $10.00. Bavarian Nordic A/S has a twelve month low of $6.86 and a twelve month high of $14.60. The company has a market capitalization of $2.12 billion, a PE ratio of 13.01 and a beta of 1.65.

Bavarian Nordic A/S Company Profile

Bavarian Nordic A/S develops, manufactures, and commercializes life-saving vaccines. The company offers non-replicating smallpox and monkeypox vaccines under the IMVAMUNE, IMVANEX, and JYNNEOS names; rabies vaccine for human use under the Rabipur/RabAvert name; tick-borne encephalitis vaccine under the Encepur name; and Ebola vaccine under the MVABEA name.